BrightSpring Health Services, Inc. (BTSG), on Friday reported its higher net income in the fourth quarter, primarily driven by strong revenue compared with the previous year.
For the fourth quarter, net income attributable to the company increased to $77.08 million from $15.40 million in the previous year.
Earnings per share were $0.23 versus $0.02 last year.
Adjusted earnings per share were $0.33 versus $0.13 last year.
EBITDA for the period rose to $147.64 million from $98.21 million in the previous year.
Adjusted EBITDA jumped to $183.555 million from $130.43 million in the same period a year ago.
Operating income surged to $108.11 billion from $55.54 million in the prior year.
Revenue increased to $3.55 billion from $2.75 billion in the previous year.
Looking ahead, the company guides full-year 2026 revenue of $14.45 billion to $15.0 billion, representing growth of 11.9% to 16.2% compared with 2025 results excluding the Community Living business.
Adjusted EBITDA is forecast in the range of $760 million to $790 million, representing growth of 23.1% to 27.9%.
The Amedisys and LHC acquisition is expected to contribute approximately $30 million in Adjusted EBITDA in 2026.
On Thursday, BrightSpring closed trading 1.64% lesser at $40.13 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.